Navigation Links
Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that two poster presentations were presented with its collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa at the XXIst Congress of the International Society on Thrombosis and Haemostasis in Geneva, Switzerland. The data presented demonstrates that GlycoPEGylation(TM) significantly prolongs the active half-life of rFVIIa. GlycoPEGylated Factor VIIa, currently in Phase I, is being developed by Novo Nordisk A/S under a license from Neose.

The posters, which were co-authored by Novo Nordisk and Neose, are titled:

-- Development of long-acting rFVIIa derivatives by GlycoPEGylation(TM)

-- Effect of GlycoPEGylation(TM) on the pharmacokinetic properties of rVIIa

The full poster presentations are available on the Neose corporate website at: http://phx.corporate-ir.net/phoenix.zhtml?c=60494&p=irol-presentations

About Coagulation Factor VII

Factor VII/VIIa is used in the treatment of bleeding episodes and for the prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors VIII or IX. The worldwide market for recombinant Factor VII was approximately $1 billion in 2006, with Novo Nordisk being the only participant.

About Neose Technologies, Inc.

Neose Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development of next-generation therapeutic proteins that are competitive with best-in-class protein drugs currently on the market, on its own and through strategic partnerships. The lead candidates in its pipeline, NE-180 for use in the treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure and GlycoPEG-GCSF for chemotherapy-induced neutropenia, target markets with aggregate sales in excess of
'"/>




Page: 1 2

Related medicine technology :

1. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:6/3/2015)... AND PITTSBURGH , June 3, 2015 /PRNewswire/ ... pharmaceutical company, today announced that the Company will present at ... Tuesday June 9, 2015. The presentation is scheduled to begin ... Interested parties can access a live webcast of the ... http://mylan.com/investors .   Mylan is a global ...
(Date:6/3/2015)...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... announced data that home hemodialysis can save ... water annually by transitioning just 20 percent of ... the NxStage® System One™.  Industry data shows conventional ... per patient per week, whereas home hemodialysis with ...
(Date:6/3/2015)... Genoa has received final approval ... organizations with proven track records for excellent service to ... for outstanding customer service, flexibility and delivering true value ... is the leading provider of pharmacy services dedicated ... managing the cost and quality of their care. The ...
Breaking Medicine Technology:Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2
... RIDGEFIELD, Conn., Oct. 24, 2011 Apelon, ... data interoperability solutions, today announced the availability ... solution. TermManager, a code set management and ... interoperability initiatives by enabling widespread access to ...
... Codexis, Inc. (Nasdaq: CDXS ) ... Codex® Screening Kits are in use or evaluation ... worldwide.  The announcement was made at CPhI  Worldwide, ... week.   Codex® Screening Kits were ...
Cached Medicine Technology:Apelon Announces Availability of New TermManager® Software 250 Pharma Companies Worldwide Now Use Codexis In Process Development 2
(Date:6/3/2015)... (PRWEB) June 03, 2015 Visual ... Analytics solutions, today announced the launch of the ... (DSX) for SAP® BusinessObjects™ Design Studio. The Design ... visualization capabilities and advanced functionalities into their dashboarding ... DSX suite, Visual BI is adding key components ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry ... grand opening with a ribbon cutting ceremony on Wednesday, ... its kind in the area, Fourroux Prosthetics will provide ... through use of patented advanced prosthetics CAD/CAM technology. ... Prosthetics, states, “Our goal has always been to provide ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 First ... freestanding emergency rooms in the United States, announced that ... facility in late June. , “I am pleased ... Texas with a new facility in the San Antonio ... of First Choice Emergency Room. , First Choice ...
(Date:6/3/2015)... Washington, DC (PRWEB) June 03, 2015 ... podiatrist Dr. Casey Friske ( Clarksville ... Podiatrist Scholarship from the Symposium of Advanced Wound Care ... by APMA President-Elect Dr. Dan Davis. The Conference ... Henry B. Gonzalez Convention Center in San Antonio, TX. ...
Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2
... -- The discovery of a gene pattern that distinguishes highly ... may help improve treatment of bone cancer in children, according ... species that develops bone cancer spontaneously with any frequency. Dogs ... human and dog forms of bone cancer are very similar, ...
... News) -- Youth sports programs need to have guidelines ... updated policy statement from the American Academy of Pediatrics. ... in outdoor sports and activities in a wide range ... situations that are potentially dangerous," Dr. Stephen G. Rice, ...
... new source for sexual problems among middle-aged and older ... men,s closest friends. A study published Monday, August ... Chicago and Cornell University has found a connection between ... men and their partners. They describe the situation as ...
... PHILADELPHIA In the latest issue of Nature ... the University of Pennsylvania clarify the role of two ... well-known protein called Notch passes off much of its ... T cells are required for many aspects of immunity, ...
... , SUNDAY, Aug. 7 (HealthDay News) -- Be ... of Michigan Health System,s Trauma Burn Center, which has treated ... kinds of injuries are avoidable and the painful consequences often ... in a news release from the trauma center. Most ...
... RIVERSIDE, Calif. ( www.ucr.edu ) -- A professor at ... has received a $100,000 grant to develop a new ... Dimitrios "Dimitri" Morikis, a professor of bioengineering, and ... Study of Macular Degeneration at the University of California, ...
Cached Medicine News:Health News:Study of Bone Cancer in Dogs May Improve Treatment in Kids 2Health News:Kids Can Safely Play Sports in Hot Weather: Experts 2Health News:When a man's partner is too close to his friends, his sex life may suffer 2Health News:When a man's partner is too close to his friends, his sex life may suffer 3Health News:Penn researchers describe key molecule that keeps immune cell development on track 2Health News:Professor fights disease that destroys vision 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: